Research Article

[Retracted] Analysis of Systolic Blood Pressure Level and Short-Term Variability in Masked Hypertension

Table 1

Comparison of baseline data of the four groups.

Normotension group (n = 62)Controlled hypertension group (n = 78)Masked hypertension group (n = 69)Sustained hypertension group (n = 41)t/Z/χ2 value

Age (years)63 (54, 68)65 (55.8, 74)63 (57, 71)75 (60, 77)10.9240.012
Male gender, n (%)44 (71.0)59 (75.6)37 (53.6)26 (63.4)8.7780.032
BMI (kg/m2)23.4 (21.6, 25.9)25.1 (23.4, 26.7)25.4 (23, 28.2)25.5 (23.8, 28.3)12.4860.006
Never smoking, n (%)31 (50.0)49 (62.8)39 (56.5)29 (70.7)5.4120.144
Drinking, n (%)15 (24.6)13 (16.7)19 (27.5)8 (19.5)5.6770.460
Physical exercise, n (%)55 (90.2)61 (78.2)53 (76.8)33 (80.5)4.5380.209
Course of hypertension (years)-10 (3.8, 20)5 (0, 18)20 (10, 25.5)123.735<0.001
Number of antihypertension drugs, n (%)94.635<0.001
060 (96.8)14 (17.9)31 (44.9)4 (9.8)
12 (3.2)23 (29.5)15 (21.7)16 (39.0)
2032 (41.0)16 (23.2)15 (36.6)
309 (11.5)6 (8.7)4 (9.8)
4001 (1.4)2 (4.9)
Clinical history, n (%)
Diabetes13 (21.0)32 (41.0)42 (60.9)18 (43.9)21.435<0.001
Hyperlipidemia42 (67.7)64 (82.1)60 (87.0)33 (80.5)7.9770.046
Chronic kidney disease05 (6.4)4 (5.8)1 (2.4)4.7140.164
Hyperuricemia18 (29.0)13 (16.7)8 (11.6)7 (17.1)7.0010.072
Coronary heart disease13 (21.0)20 (25.6)20 (29.0)10 (24.4)1.1360.768
Sleep apnea syndrome8 (13.1)16 (20.5)14 (20.3)2 (4.9)6.2570.100
Laboratory parameters
TG (mmol/L)1.2 (0.8, 2)1.5 (1.1, 2.1)1.5 (1, 2.1)1.2 (0.9, 1.6)8.6450.034
TC (mmol/L)4.3 (3.7, 5)4.1 (3.6, 4.5)4.5 (3.7, 5)4.1 (3.5, 5)4.4600.216
LDL-C (mmol/L)2.5 (1.8, 3.1)2.2 (1.8, 2.7)2.7 (1.8, 3.1)2.4 (1.8, 2.8)4.9450.176
HDL-C (mmol/L)1.1 (0.9, 1.4)1 (0.9, 1.2)1 (0.9, 1.4)1.1 (0.9, 1.3)3.9270.269
FBG (mmol/L)5.1 (4.8, 5.7)5.4 (4.9, 6.1)5.7 (5.2, 7)5.4 (4.9, 6.4)13.9500.003
HbA1c (%)5.7 (5.5, 6.3)6.1 (5.7, 6.6)6.3 (5.9, 7)6.1 (5.9, 6.8)21.847<0.001

Bold values represent the significant difference.